incb106385
Incb106385 is a drug used to treat Advanced Solid Tumors, Bladder Cancer, Castration Resistant Prostate Cancer, and other conditions. Incb106385 is being actively studied in 2 studies; no studies for this drug have been completed so far.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Incyte Corporation | Cliniques Universitaires Ucl Saint-Luc | |
| Fundacion Jimenez Diaz University Hospital | ||
| Hospital General Universitario Vall D Hebron |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
I
Recruiting
- Ovarian Cancer
- +10 more
- INCB106385
- INCMGA00012
- West Hollywood, California
- +26 more
2022-04-06
Apr 6, 2022I
Recruiting
- Advanced Solid Tumors
- +2 more
- INCA00186
- +2 more
- Los Angeles, California
- +21 more
2022-03-23
Mar 23, 2022